Experience

Our recent experience includes middle‑market transactions for corporations, investors, and SPVs across aerospace and defense, natural resources, TMT, manufacturing, and biotechnology. In aerospace and defense, our work has included acquisitions for low‑Earth‑orbit satellite businesses and corporate transactions involving defense and space platforms. In financial and other services, we have advised on growth‑through‑acquisition strategies for FINRA‑member firms shifting toward technology‑driven models. In media and entertainment, our mandates have centered on acquisitions of content‑related assets.

Across energy, infrastructure, and industrials, recent engagements have included advisory on growth and pre‑IPO financings for renewable energy and data center platforms with associated real estate, platform and follow‑on capital structures for funds focused on natural resources, and transactions in industrial and manufacturing contexts where capacity, throughput, and supply‑chain behavior are central. In biotechnology and life sciences, our experience has focused on post‑clinical‑stage drug companies considering alternatives such as growth equity, structured credit, and risk‑sharing arrangements after key trial milestones.

These engagements include mergers and acquisitions, SPVs, growth and pre‑IPO financings, recapitalizations, and other transaction types across the middle market.